Subsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab

EJ
HCPCS Modifier Code

2023 HCPCS Modifiers
Billable/Valid Code

EJ is a valid 2023 HCPCS Modifier that could be used to indicate Subsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab.

EJ Modifier has been in effect since Jan 01, 2000.

Short description for EJ HCPCS Modifier code:

Subsequent claim

HCPCS EJ MODIFIER

EJ Modifier information

Modifier:	EJ
Description:	SUBSEQUENT CLAIMS FOR A DEFINED COURSE OF THERAPY, E.G., EPO, SODIUM HYALURONATE, INFLIXIMAB
Effective Date:	Jan 01, 2000
Added Date:	Jan 01, 1991
Coverage code:	`D` - SPECIAL COVERAGE INSTRUCTIONS APPLY
Action code:	`N` - NO MAINTENANCE FOR THIS CODE